Genzyme and Isis announce FDA approval of KYNAMRO™ injection for the treatment of HoFH
“Today’s FDA approval of KYNAMRO is great news..."
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
List view / Grid view
“Today’s FDA approval of KYNAMRO is great news..."
29 January 2013 | By Sanofi
“Today’s FDA approval of KYNAMRO is great news..."
Biogen Idec and Isis Pharmaceuticals, Inc. have entered into an…
4 January 2012 | By Biogen Idec
Biogen Idec and Isis Pharmaceuticals, Inc. have entered into an exclusive, worldwide option and collaboration agreement...